Pentasa is specifically formulated to release mesalazine slowly and continuously throughout the gastrointestinal tract, primarily targeting the colon, where inflammation typically occurs in ulcerative colitis. By reducing inflammation in the colon, Pentasa helps to relieve symptoms and maintain remission in patients with ulcerative colitis.